Catherine Bollard received her medical degree at the University of Otago in Dunedin, New Zealand. She is Board certified both in Pediatrics and Hematology.  She worked both in New Zealand and London, England before moving to Baylor College of Medicine (BCM) in 2000 where she was Professor of Pediatrics, Medicine and Immunology and the Director of the Texas Children’s Cancer and Hematology Center Pediatric Lymphoma Program. In August 2013, she moved to Washington DC to join Children’s National Hospital and The George Washington University School of Medicine and Health Sciences. She is currently the Bosworth Chair for Cancer Biology, Director of the Center for Cancer and Immunology Research, and director of the Program for Cell Enhancement and Technologies for Immunotherapy (CETI) at Children’s National. She is a Professor of Pediatrics and of Microbiology, Immunology and Tropical Medicine at The George Washington University and Associate Center Director for Translational Research and Innovation at the GW Cancer Center. She is a member of the American Society for Clinical Investigation (ASCI) and is a Past President of the International Society for Cellular Therapy (ISCT) and is the current President of the Foundation for the Accreditation of Cellular Therapy (FACT). She chaired the Non Hodgkins Lymphoma committee of the Children’s Oncology Group from 2012-2020. She was an Associate Editor for the journals Blood and Cytotherapy and in 2021 became the Editor in Chief of Blood Advances. She also served as a member of the NCI Clinical Oncology Study Section and the Cellular, Tissues and Gene Therapies Advisory Committee for the Food and Drug Administration (FDA). Her bench and translational research focuses on improving outcomes for patients after hematopoietic stem cell transplantation and on the development of novel cell therapies for viral diseases and cancer.